Napigen Inc.

Wilmington, DE

UEI
KJD2HMU4QDK5
CAGE
7QU54
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
200 Powder Mill Rd, Wilmington, DE 19803, USA
Website
napigen.com
Founded
2016
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Napigen Inc.

Napigen Inc. is a for-profit corporation specializing in innovative plant biotechnology, particularly focused on mitochondrial gene editing and transformation technologies. The company develops advanced methods for modifying plant mitochondrial DNA to create crop varieties with enhanced traits such as herbicide resistance, improved nitrogen use efficiency, and drought tolerance. Napigen's work aims to address major agricultural challenges and improve crop productivity and sustainability. Since its registration with SAM.gov in October 2016, Napigen has secured multiple federal grant awards from agencies such as the U.S. Department of Agriculture (USDA) and the National Institutes of Health (NIH) to support its cutting-edge research and development efforts.

Through its federal grant awards, Napigen Inc. has undertaken several significant projects in agricultural biotechnology and medical research. The company received a $175,000 Project Grant from the USDA's National Institute of Food and Agriculture (NIFA) under the Small Business Innovation Research (SBIR) program to develop rice plants with herbicide resistance genes integrated into the mitochondrial genome. This innovative approach aims to prevent the transfer of resistance to weeds through pollen, addressing a major challenge for rice farmers globally. Napigen has also worked on developing mitochondrial transformation technologies for creating elite hybrid wheat, supported by another USDA NIFA grant. Additionally, the company has expanded its research into human health applications, receiving funding from the National Institute of General Medical Sciences (NIH) to adapt its plant mitochondrial transformation technology for editing human mitochondrial DNA. This project aims to facilitate future gene therapy treatments for mitochondrial diseases, demonstrating Napigen's ability to translate its agricultural biotechnology expertise into potential medical breakthroughs.

Quick answers

What is Napigen Inc.'s UEI?

Napigen Inc.'s Unique Entity ID (UEI) in SAM.gov is KJD2HMU4QDK5.

What is Napigen Inc.'s CAGE code?

Napigen Inc.'s CAGE code is 7QU54.

Where is Napigen Inc. located?

Napigen Inc.'s physical address in SAM.gov is 200 Powder Mill Rd, Wilmington, DE 19803, USA.

Is Napigen Inc. registered in SAM.gov?

Yes. Napigen Inc.'s SAM.gov registration is active through March 19, 2027.

What is Napigen Inc.'s most recent federal award?

Napigen Inc.'s most recent federal grant award is **awards issued prior to january 20, 2025, were funded under previous administrations and may not reflect the priorities… (20247050141924), from Institute of Food Production and Sustainability, on July 1, 2024.

On GovTribe

See Napigen Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors